HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- (2- (4- chloro- 1H- pyrazol- 1- yl)ethylamino)- 3- (6- (1- (3- fluoropropyl)piperidin- 4- yl)- 4- methyl- 1H- benzo(d)imidazol- 2- yl)pyridin- 2(1H)- one

inhibits insulin-like growth factor-1 receptor kinase; structure in first source

Also Known As:

BMS 695735; BMS-695735; BMS695735

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Pyridones: 14
      - 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo(d)imidazol-2-yl)pyridin-2(1H)-one
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo(d)imidazol-2-yl)pyridin-2(1H)-one